Monitoring for catheter-based treatments
CloudCath develops technology designed to remove patient monitoring complications for patients undergoing catheter-based treatments. The remote monitoring system analyzes drainage fluid and uses proprietary algorithms to detect fluid property deviations, transmitting notifications to healthcare providers automatically.
The company closed a $12 million financing round in January, earmarking the funds for its at-home dialysis monitoring treatment platform, plus the development of additional applications. –SW
Investors include: Capital Integral, Coconut Tree Investments, FundRx, Hanawa Group, r42 Group